SomaLogic In Deal With Agilent

Boulder-based SomaLogic, the developer of protein biomarker tools for clinical diagnostics, has expanded a deal with Agilent Technologies, the companies said yesterday. Accordign to the two, they are in an agreement to expand access to SomaLogic's protein biomarker discovery platform, by placing that technology in selected academic and contract research centers. SomaLogic's product are tied into Agilent's microarray products. Financial terms of the deal were not disclosed.